|
|||||
|
|
Economic value of regular monitoring of response to treatment among US patients with chronic myeloid leukemia based on an economic model |
|
| Authors: | Elias J Jabbour Lisa R Siegartel Jay Lin Melissa Lingohr-Smith Brandy Menges Dinara Makenbaeva |
| Institution: | 1. The University of Texas MD Anderson Cancer Center, Houston, TX, USA;2. ejabbour@mdanderson.org;4. Bristol-Myers Squibb, Princeton, NJ, USA;5. Novosys Health, Green Brook, NJ, USA |
| Abstract: | |
| Keywords: | Chronic myeloid leukemia molecular monitoring economic model healthcare costs |